CryoLife (CRY) Reports Q2 EPS of $0.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Piper Jaffray Remains Bullish on CryoLife (CRY) Following 2Q Report
July 26, 2016 7:54 AM EDTPiper Jaffray reiterated an Overweight rating and $16.00 price target on CryoLife (NYSE: CRY) following the company's 2Q earnings report. CRY reported revenue of $47.1M, driven by recently acquired On-X, improvements to the vascular tissue business, and strong BioGlue sales. Adjusted cash EPS of $0.13 beat the consensus of $0.07.... More



